Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04543071
Title Chemo4METPANC Combination Chemotherapy in Patients With Pancreatic Adenocarcinoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gulam Manji

pancreatic adenocarcinoma


BKT140 + Cemiplimab + Gemcitabine + Nab-paclitaxel

Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.